Your browser doesn't support javascript.
loading
Pyrrolosporin A, a new antitumor antibiotic from Micromonospora sp. C39217-R109-7. I. Taxonomy of producing organism, fermentation and biological activity.
Lam, K S; Hesler, G A; Gustavson, D R; Berry, R L; Tomita, K; MacBeth, J L; Ross, J; Miller, D; Forenza, S.
Affiliation
  • Lam KS; Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA.
J Antibiot (Tokyo) ; 49(9): 860-4, 1996 Sep.
Article in En | MEDLINE | ID: mdl-8931718
ABSTRACT
Strain C39217-R109-7 (ATCC 53791) is an actinomycete strain isolated from a soil sample collected at Puerto Viejo, Peru. It produces a new antitumor antibiotic, designated pyrrolosporin A. Taxonomic studies on its morphological, cultural and physiological characteristics identified this producing strain as Micromonospora sp. C39217-R109-7. Pyrrolosporin A shows antimicrobial activity against Gram-positive bacteria and it is weakly active against Gram-negative bacteria. Pyrrolosporin A prolongs the life span of mice inoculated with P388 leukemia cells.
Subject(s)
Search on Google
Database: MEDLINE Main subject: Macrolides / Fermentation / Micromonospora / Anti-Bacterial Agents / Antibiotics, Antineoplastic Type of study: Prognostic_studies Limits: Animals Language: En Year: 1996 Type: Article
Search on Google
Database: MEDLINE Main subject: Macrolides / Fermentation / Micromonospora / Anti-Bacterial Agents / Antibiotics, Antineoplastic Type of study: Prognostic_studies Limits: Animals Language: En Year: 1996 Type: Article